To examine whether these effects are via MIG-7 and phospho-PHBT258 - the active PHB molecule in membrane rafts [9], we treated lung cancer cells with EGF, HGF, IGF-1 and PGE2, respectively. The gene discussed is EGF; the disease is lung carcinoma.